Apiksabaani (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apiksabaani" in Finnish language version.

refsWebsite

Global rank Finnish rank

2^nd place

10^th place

5^th place

9^th place

4^th place

12^th place

68^th place

51^st place

274^th place

418^th place

399^th place

2,670^th place

1omicsonline.org

low place

low place

1terveyskirjasto.fi

8,115^th place

35^th place

low place

165^th place

1web.archive.org

1^st place

1^st place

doi.org

dx.doi.org

W Byon et al: Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clinical Pharmacokinetics, 2019, s. 1–15. doi:10.1007/s40262-019-00775-z ISSN 0312-5963 Artikkelin verkkoversio.
DJ Sen: Xabans as direct factor Xa inhibitors. Journal of Bioanalysis & Biomedicine, 2015, 7. vsk, nro 1. doi:10.4172/1948-593X.1000e127 ISSN 1948-593X Artikkelin verkkoversio.
S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411 doi:10.4103/0019-5049.144643 ISSN 0019-5049 Artikkelin verkkoversio.
W Mueck, S Schwers, J Stampfuss: Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring. Thrombosis Journal, 2013, 11. vsk, nro 1, s. 10. PubMed:23809871 doi:10.1186/1477-9560-11-10 ISSN 1477-9560 Artikkelin verkkoversio.

drugs.com

Apixaban Drugs.com. Viitattu 6.9.2019.

europa.eu

ema.europa.eu

Valmisteyhteenveto (PDF) ema.europa.eu.
Ondexxya International non-proprietary name: andexanet alfa. European Medicines Agency, 2019, s. 11–17. Artikkelin verkkoversio.

fimea.fi

sic.fimea.fi

A Kalliokoski: Uusien oraalisten antikoagulanttien käyttöaiheet laajenevat – Sic! sic.fimea.fi. Arkistoitu 5.11.2019. Viitattu 7.9.2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411 doi:10.4103/0019-5049.144643 ISSN 0019-5049 Artikkelin verkkoversio.
W Mueck, S Schwers, J Stampfuss: Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring. Thrombosis Journal, 2013, 11. vsk, nro 1, s. 10. PubMed:23809871 doi:10.1186/1477-9560-11-10 ISSN 1477-9560 Artikkelin verkkoversio.

ncbi.nlm.nih.gov

S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411 doi:10.4103/0019-5049.144643 ISSN 0019-5049 Artikkelin verkkoversio.
W Mueck, S Schwers, J Stampfuss: Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring. Thrombosis Journal, 2013, 11. vsk, nro 1, s. 10. PubMed:23809871 doi:10.1186/1477-9560-11-10 ISSN 1477-9560 Artikkelin verkkoversio.

omicsonline.org

DJ Sen: Xabans as direct factor Xa inhibitors. Journal of Bioanalysis & Biomedicine, 2015, 7. vsk, nro 1. doi:10.4172/1948-593X.1000e127 ISSN 1948-593X Artikkelin verkkoversio.

springer.com

link.springer.com

W Byon et al: Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clinical Pharmacokinetics, 2019, s. 1–15. doi:10.1007/s40262-019-00775-z ISSN 0312-5963 Artikkelin verkkoversio.

terveyskirjasto.fi

Eliquis Duodecim – Terveyskirjasto. Viitattu 6.9.2019.^{[vanhentunut linkki]}

web.archive.org

A Kalliokoski: Uusien oraalisten antikoagulanttien käyttöaiheet laajenevat – Sic! sic.fimea.fi. Arkistoitu 5.11.2019. Viitattu 7.9.2019.

worldcat.org

W Byon et al: Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clinical Pharmacokinetics, 2019, s. 1–15. doi:10.1007/s40262-019-00775-z ISSN 0312-5963 Artikkelin verkkoversio.
DJ Sen: Xabans as direct factor Xa inhibitors. Journal of Bioanalysis & Biomedicine, 2015, 7. vsk, nro 1. doi:10.4172/1948-593X.1000e127 ISSN 1948-593X Artikkelin verkkoversio.
S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411 doi:10.4103/0019-5049.144643 ISSN 0019-5049 Artikkelin verkkoversio.
W Mueck, S Schwers, J Stampfuss: Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring. Thrombosis Journal, 2013, 11. vsk, nro 1, s. 10. PubMed:23809871 doi:10.1186/1477-9560-11-10 ISSN 1477-9560 Artikkelin verkkoversio.